Quick Summary:
In today's rapidly evolving healthcare landscape, a nuanced, data-driven understanding of market trends is key to success. Direct your attention to the global market for Lipase; poised for robust growth, this sector stands at an impressive estimate of US$464.3 Million in 2022, forecasted to escalate and attain a revised size of US$611.9 Million by 2030.
This comprehensive market research report provides an invaluable opportunity for strategic positioning. Keep your business ahead of the curve with detailed insights into the Lipase market. The report segments and analyzes market subsectors, including Microbial and Animal Lipases, providing growth predictions for each segment. It also includes regional analysis with a particular spotlight on markets such as the U.S., China, Japan, Canada, and Germany. Stay ahead of current trends and anticipate future ones. Whatever your strategic goals may be, this report offers the vital data necessary to guide your decision-making.
Global Lipase Market to Reach $611.9 Million by 2030
The global market for Lipase estimated at US$464.3 Million in the year 2022, is projected to reach a revised size of US$611.9 Million by 2030, growing at a CAGR of 3.5% over the analysis period 2022-2030. Microbial Lipases, one of the segments analyzed in the report, is projected to record 3.4% CAGR and reach US$461.5 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Animal Lipases segment is readjusted to a revised 3.9% CAGR for the next 8-year period.The U.S. Market is Estimated at $126.5 Million, While China is Forecast to Grow at 6.1% CAGR
The Lipase market in the U.S. is estimated at US$126.5 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$125 Million by the year 2030 trailing a CAGR of 6.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.8% and 4.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 1.7% CAGR.Select Competitors (Total 46 Featured) -
- Advanced Enzymes Technologies Ltd.
- Amano Enzyme, Inc.
- Associated British Foods PLC
- Chr. Hansen Holdings A/S
- Clerici-Sacco Group
- Dow, Inc.
- DuPont de Nemours, Inc.
- Enzyme Development Corporation
- Koninklijke DSM NV
- Novozymes A/S
- Renco New Zealand
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Lipase?
What is the growth rate of the Global Market for Lipase?
What is the forecasted size of the Global Market for Lipase?
Who are the key companies in the Global Market for Lipase?
Report Attribute | Details |
---|---|
No. of Pages | 196 |
Published | December 2023 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 464.3 Million |
Forecasted Market Value ( USD | $ 611.9 Million |
Compound Annual Growth Rate | 3.5% |
Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Advanced Enzymes Technologies Ltd.
- Amano Enzyme, Inc.
- Associated British Foods PLC
- Chr. Hansen Holdings A/S
- Clerici-Sacco Group
- Dow, Inc.
- DuPont de Nemours, Inc.
- Enzyme Development Corporation
- Koninklijke DSM NV
- Novozymes A/S
- Renco New Zealand